 | • レポートコード：MRC2-11QY04317 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はポイントオブケア感染症診断のグローバル市場について調査・分析したレポートです。種類別（HIV POC、クロストリジウムディフィシルPOC、HBV POC、呼吸器合胞体ウイルスPOC、HPV POC、インフルエンザ/インフルエンザPOC、HCV POC、MRSA POC、TBおよび薬剤耐性結核POC）市場規模、用途別（病院、診療所、家庭用、生活支援医療施設、研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ポイントオブケア感染症診断の競争状況、市場シェア ・世界のポイントオブケア感染症診断市場：種類別市場規模 2015年-2020年（HIV POC、クロストリジウムディフィシルPOC、HBV POC、呼吸器合胞体ウイルスPOC、HPV POC、インフルエンザ/インフルエンザPOC、HCV POC、MRSA POC、TBおよび薬剤耐性結核POC） ・世界のポイントオブケア感染症診断市場：種類別市場規模予測 2021年-2026年（HIV POC、クロストリジウムディフィシルPOC、HBV POC、呼吸器合胞体ウイルスPOC、HPV POC、インフルエンザ/インフルエンザPOC、HCV POC、MRSA POC、TBおよび薬剤耐性結核POC） ・世界のポイントオブケア感染症診断市場：用途別市場規模 2015年-2020年（病院、診療所、家庭用、生活支援医療施設、研究所、その他） ・世界のポイントオブケア感染症診断市場：用途別市場規模予測 2021年-2026年（病院、診療所、家庭用、生活支援医療施設、研究所、その他） ・北米のポイントオブケア感染症診断市場分析：米国、カナダ ・ヨーロッパのポイントオブケア感染症診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのポイントオブケア感染症診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のポイントオブケア感染症診断市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのポイントオブケア感染症診断市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Thermo Fisher Scientific、Abbott、Calypte Biomedical、Chembio Diagnostic Systems、Meridian Bioscience、MedMira、Trinity Biotech、Sekisui Diagnostics、OraSure Technologies、Quidel ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Point of care diagnosis allows for early detection of diseases and can greatly impact the medical outcome of the disease treatment.
The point-of-care infectious disease diagnostics market is expected to register a fast growth over the forecast period owing to the emerging trend of patient-centric services and escalating incidence rates of complicated infectious disorders.
Market Analysis and Insights: Global Point-of-care Infectious Disease Diagnostics Market
The global Point-of-care Infectious Disease Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Point-of-care Infectious Disease Diagnostics Scope and Market Size
Point-of-care Infectious Disease Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Point-of-care Infectious Disease Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Thermo Fisher Scientific
Abbott
Calypte Biomedical
Chembio Diagnostic Systems
Meridian Bioscience
MedMira
Trinity Biotech
Sekisui Diagnostics
OraSure Technologies
Quidel
Market segment by Type, the product can be split into
HIV POC
Clostridium Difficile POC
HBV POC
Respiratory Syncytial Virus POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and Drug-Resistant TB POC
Market segment by Application, split into
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Point-of-care Infectious Disease Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 HIV POC
1.4.3 Clostridium Difficile POC
1.4.4 HBV POC
1.4.5 Respiratory Syncytial Virus POC
1.4.6 HPV POC
1.4.7 Influenza/Flu POC
1.4.8 HCV POC
1.4.9 MRSA POC
1.4.10 TB and Drug-Resistant TB POC
1.5 Market by Application
1.5.1 Global Point-of-care Infectious Disease Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Home
1.5.5 Assisted Living Healthcare Facilities
1.5.6 Laboratories
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Point-of-care Infectious Disease Diagnostics Market Perspective (2015-2026)
2.2 Global Point-of-care Infectious Disease Diagnostics Growth Trends by Regions
2.2.1 Point-of-care Infectious Disease Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Point-of-care Infectious Disease Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Point-of-care Infectious Disease Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Point-of-care Infectious Disease Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Point-of-care Infectious Disease Diagnostics Players by Market Size
3.1.1 Global Top Point-of-care Infectious Disease Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Point-of-care Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Point-of-care Infectious Disease Diagnostics Market Concentration Ratio
3.2.1 Global Point-of-care Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Point-of-care Infectious Disease Diagnostics Revenue in 2019
3.3 Point-of-care Infectious Disease Diagnostics Key Players Head office and Area Served
3.4 Key Players Point-of-care Infectious Disease Diagnostics Product Solution and Service
3.5 Date of Enter into Point-of-care Infectious Disease Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Point-of-care Infectious Disease Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020)
5.2 Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Point-of-care Infectious Disease Diagnostics Market Size (2015-2020)
6.2 Point-of-care Infectious Disease Diagnostics Key Players in North America (2019-2020)
6.3 North America Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020)
6.4 North America Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Point-of-care Infectious Disease Diagnostics Market Size (2015-2020)
7.2 Point-of-care Infectious Disease Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020)
7.4 Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China Point-of-care Infectious Disease Diagnostics Market Size (2015-2020)
8.2 Point-of-care Infectious Disease Diagnostics Key Players in China (2019-2020)
8.3 China Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020)
8.4 China Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Point-of-care Infectious Disease Diagnostics Market Size (2015-2020)
9.2 Point-of-care Infectious Disease Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020)
9.4 Japan Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size (2015-2020)
10.2 Point-of-care Infectious Disease Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India Point-of-care Infectious Disease Diagnostics Market Size (2015-2020)
11.2 Point-of-care Infectious Disease Diagnostics Key Players in India (2019-2020)
11.3 India Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020)
11.4 India Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Point-of-care Infectious Disease Diagnostics Market Size (2015-2020)
12.2 Point-of-care Infectious Disease Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Thermo Fisher Scientific
13.1.1 Thermo Fisher Scientific Company Details
13.1.2 Thermo Fisher Scientific Business Overview
13.1.3 Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Introduction
13.1.4 Thermo Fisher Scientific Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020))
13.1.5 Thermo Fisher Scientific Recent Development
13.2 Abbott
13.2.1 Abbott Company Details
13.2.2 Abbott Business Overview
13.2.3 Abbott Point-of-care Infectious Disease Diagnostics Introduction
13.2.4 Abbott Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)
13.2.5 Abbott Recent Development
13.3 Calypte Biomedical
13.3.1 Calypte Biomedical Company Details
13.3.2 Calypte Biomedical Business Overview
13.3.3 Calypte Biomedical Point-of-care Infectious Disease Diagnostics Introduction
13.3.4 Calypte Biomedical Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)
13.3.5 Calypte Biomedical Recent Development
13.4 Chembio Diagnostic Systems
13.4.1 Chembio Diagnostic Systems Company Details
13.4.2 Chembio Diagnostic Systems Business Overview
13.4.3 Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Introduction
13.4.4 Chembio Diagnostic Systems Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)
13.4.5 Chembio Diagnostic Systems Recent Development
13.5 Meridian Bioscience
13.5.1 Meridian Bioscience Company Details
13.5.2 Meridian Bioscience Business Overview
13.5.3 Meridian Bioscience Point-of-care Infectious Disease Diagnostics Introduction
13.5.4 Meridian Bioscience Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)
13.5.5 Meridian Bioscience Recent Development
13.6 MedMira
13.6.1 MedMira Company Details
13.6.2 MedMira Business Overview
13.6.3 MedMira Point-of-care Infectious Disease Diagnostics Introduction
13.6.4 MedMira Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)
13.6.5 MedMira Recent Development
13.7 Trinity Biotech
13.7.1 Trinity Biotech Company Details
13.7.2 Trinity Biotech Business Overview
13.7.3 Trinity Biotech Point-of-care Infectious Disease Diagnostics Introduction
13.7.4 Trinity Biotech Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)
13.7.5 Trinity Biotech Recent Development
13.8 Sekisui Diagnostics
13.8.1 Sekisui Diagnostics Company Details
13.8.2 Sekisui Diagnostics Business Overview
13.8.3 Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Introduction
13.8.4 Sekisui Diagnostics Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)
13.8.5 Sekisui Diagnostics Recent Development
13.9 OraSure Technologies
13.9.1 OraSure Technologies Company Details
13.9.2 OraSure Technologies Business Overview
13.9.3 OraSure Technologies Point-of-care Infectious Disease Diagnostics Introduction
13.9.4 OraSure Technologies Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)
13.9.5 OraSure Technologies Recent Development
13.10 Quidel
13.10.1 Quidel Company Details
13.10.2 Quidel Business Overview
13.10.3 Quidel Point-of-care Infectious Disease Diagnostics Introduction
13.10.4 Quidel Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020)
13.10.5 Quidel Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Point-of-care Infectious Disease Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Point-of-care Infectious Disease Diagnostics Revenue
Table 3. Ranking of Global Top Point-of-care Infectious Disease Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of HIV POC
Table 6. Key Players of Clostridium Difficile POC
Table 7. Key Players of HBV POC
Table 8. Key Players of Respiratory Syncytial Virus POC
Table 9. Key Players of HPV POC
Table 10. Key Players of Influenza/Flu POC
Table 11. Key Players of HCV POC
Table 12. Key Players of MRSA POC
Table 13. Key Players of TB and Drug-Resistant TB POC
Table 14. Global Point-of-care Infectious Disease Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Point-of-care Infectious Disease Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Point-of-care Infectious Disease Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Point-of-care Infectious Disease Diagnostics Market Share by Regions (2015-2020)
Table 18. Global Point-of-care Infectious Disease Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Point-of-care Infectious Disease Diagnostics Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Point-of-care Infectious Disease Diagnostics Market Growth Strategy
Table 24. Main Points Interviewed from Key Point-of-care Infectious Disease Diagnostics Players
Table 25. Global Point-of-care Infectious Disease Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 26. Global Point-of-care Infectious Disease Diagnostics Market Share by Players (2015-2020)
Table 27. Global Top Point-of-care Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-of-care Infectious Disease Diagnostics as of 2019)
Table 28. Global Point-of-care Infectious Disease Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Point-of-care Infectious Disease Diagnostics Product Solution and Service
Table 31. Date of Enter into Point-of-care Infectious Disease Diagnostics Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 34. Global Point-of-care Infectious Disease Diagnostics Market Size Share by Type (2015-2020)
Table 35. Global Point-of-care Infectious Disease Diagnostics Revenue Market Share by Type (2021-2026)
Table 36. Global Point-of-care Infectious Disease Diagnostics Market Size Share by Application (2015-2020)
Table 37. Global Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 38. Global Point-of-care Infectious Disease Diagnostics Market Size Share by Application (2021-2026)
Table 39. North America Key Players Point-of-care Infectious Disease Diagnostics Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Point-of-care Infectious Disease Diagnostics Market Share (2019-2020)
Table 41. North America Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 42. North America Point-of-care Infectious Disease Diagnostics Market Share by Type (2015-2020)
Table 43. North America Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 44. North America Point-of-care Infectious Disease Diagnostics Market Share by Application (2015-2020)
Table 45. Europe Key Players Point-of-care Infectious Disease Diagnostics Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Point-of-care Infectious Disease Diagnostics Market Share (2019-2020)
Table 47. Europe Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Point-of-care Infectious Disease Diagnostics Market Share by Type (2015-2020)
Table 49. Europe Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Point-of-care Infectious Disease Diagnostics Market Share by Application (2015-2020)
Table 51. China Key Players Point-of-care Infectious Disease Diagnostics Revenue (2019-2020) (Million US$)
Table 52. China Key Players Point-of-care Infectious Disease Diagnostics Market Share (2019-2020)
Table 53. China Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 54. China Point-of-care Infectious Disease Diagnostics Market Share by Type (2015-2020)
Table 55. China Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 56. China Point-of-care Infectious Disease Diagnostics Market Share by Application (2015-2020)
Table 57. Japan Key Players Point-of-care Infectious Disease Diagnostics Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Point-of-care Infectious Disease Diagnostics Market Share (2019-2020)
Table 59. Japan Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Point-of-care Infectious Disease Diagnostics Market Share by Type (2015-2020)
Table 61. Japan Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Point-of-care Infectious Disease Diagnostics Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Point-of-care Infectious Disease Diagnostics Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Point-of-care Infectious Disease Diagnostics Market Share (2019-2020)
Table 65. Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Point-of-care Infectious Disease Diagnostics Market Share by Type (2015-2020)
Table 67. Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Point-of-care Infectious Disease Diagnostics Market Share by Application (2015-2020)
Table 69. India Key Players Point-of-care Infectious Disease Diagnostics Revenue (2019-2020) (Million US$)
Table 70. India Key Players Point-of-care Infectious Disease Diagnostics Market Share (2019-2020)
Table 71. India Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 72. India Point-of-care Infectious Disease Diagnostics Market Share by Type (2015-2020)
Table 73. India Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 74. India Point-of-care Infectious Disease Diagnostics Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Point-of-care Infectious Disease Diagnostics Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Point-of-care Infectious Disease Diagnostics Market Share (2019-2020)
Table 77. Central & South America Point-of-care Infectious Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Point-of-care Infectious Disease Diagnostics Market Share by Type (2015-2020)
Table 79. Central & South America Point-of-care Infectious Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Point-of-care Infectious Disease Diagnostics Market Share by Application (2015-2020)
Table 81. Thermo Fisher Scientific Company Details
Table 82. Thermo Fisher Scientific Business Overview
Table 83. Thermo Fisher Scientific Product
Table 84. Thermo Fisher Scientific Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020) (Million US$)
Table 85. Thermo Fisher Scientific Recent Development
Table 86. Abbott Company Details
Table 87. Abbott Business Overview
Table 88. Abbott Product
Table 89. Abbott Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020) (Million US$)
Table 90. Abbott Recent Development
Table 91. Calypte Biomedical Company Details
Table 92. Calypte Biomedical Business Overview
Table 93. Calypte Biomedical Product
Table 94. Calypte Biomedical Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020) (Million US$)
Table 95. Calypte Biomedical Recent Development
Table 96. Chembio Diagnostic Systems Company Details
Table 97. Chembio Diagnostic Systems Business Overview
Table 98. Chembio Diagnostic Systems Product
Table 99. Chembio Diagnostic Systems Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020) (Million US$)
Table 100. Chembio Diagnostic Systems Recent Development
Table 101. Meridian Bioscience Company Details
Table 102. Meridian Bioscience Business Overview
Table 103. Meridian Bioscience Product
Table 104. Meridian Bioscience Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020) (Million US$)
Table 105. Meridian Bioscience Recent Development
Table 106. MedMira Company Details
Table 107. MedMira Business Overview
Table 108. MedMira Product
Table 109. MedMira Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020) (Million US$)
Table 110. MedMira Recent Development
Table 111. Trinity Biotech Company Details
Table 112. Trinity Biotech Business Overview
Table 113. Trinity Biotech Product
Table 114. Trinity Biotech Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020) (Million US$)
Table 115. Trinity Biotech Recent Development
Table 116. Sekisui Diagnostics Business Overview
Table 117. Sekisui Diagnostics Product
Table 118. Sekisui Diagnostics Company Details
Table 119. Sekisui Diagnostics Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020) (Million US$)
Table 120. Sekisui Diagnostics Recent Development
Table 121. OraSure Technologies Company Details
Table 122. OraSure Technologies Business Overview
Table 123. OraSure Technologies Product
Table 124. OraSure Technologies Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020) (Million US$)
Table 125. OraSure Technologies Recent Development
Table 126. Quidel Company Details
Table 127. Quidel Business Overview
Table 128. Quidel Product
Table 129. Quidel Revenue in Point-of-care Infectious Disease Diagnostics Business (2015-2020) (Million US$)
Table 130. Quidel Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Point-of-care Infectious Disease Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. HIV POC Features
Figure 3. Clostridium Difficile POC Features
Figure 4. HBV POC Features
Figure 5. Respiratory Syncytial Virus POC Features
Figure 6. HPV POC Features
Figure 7. Influenza/Flu POC Features
Figure 8. HCV POC Features
Figure 9. MRSA POC Features
Figure 10. TB and Drug-Resistant TB POC Features
Figure 11. Global Point-of-care Infectious Disease Diagnostics Market Share by Application: 2020 VS 2026
Figure 12. Hospitals Case Studies
Figure 13. Clinics Case Studies
Figure 14. Home Case Studies
Figure 15. Assisted Living Healthcare Facilities Case Studies
Figure 16. Laboratories Case Studies
Figure 17. Others Case Studies
Figure 18. Point-of-care Infectious Disease Diagnostics Report Years Considered
Figure 19. Global Point-of-care Infectious Disease Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 20. Global Point-of-care Infectious Disease Diagnostics Market Share by Regions: 2020 VS 2026
Figure 21. Global Point-of-care Infectious Disease Diagnostics Market Share by Regions (2021-2026)
Figure 22. Porter's Five Forces Analysis
Figure 23. Global Point-of-care Infectious Disease Diagnostics Market Share by Players in 2019
Figure 24. Global Top Point-of-care Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-of-care Infectious Disease Diagnostics as of 2019
Figure 25. The Top 10 and 5 Players Market Share by Point-of-care Infectious Disease Diagnostics Revenue in 2019
Figure 26. North America Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Europe Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. China Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Japan Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Southeast Asia Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. India Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 32. Central & South America Point-of-care Infectious Disease Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 33. Bottom-up and Top-down Approaches for This Report
Figure 34. Data Triangulation
Figure 35. Key Executives Interviewed
ポイントオブケア感染性疾患の世界市場（～2026年） A point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system, has a rapid turnaround time (approximately 15 min), and provides actionable information that can lead to a change in patient management. Market Analysis and Insights: Global Point…- 感染症検査における分子診断の世界市場（～2026年） Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used …
- 呼吸器合胞体ウイルス診断の世界市場（～2026年） Products of the respiratory syncytial virus diagnostics market includes direct fluorescent antibody (DFA) method, rapid antigen diagnostic test (RADTs), molecular diagnostics, chromatographic immunoassay, diagnostic imaging, gel microdroplets, flow cytometry, and others. North America dominates the …
- ポイントオブケア診断（POCD）の世界市場（～2026年） Point of care tests, also called near-patient testing or bedside testing, refers to the performance of diagnostic tests at or near the site where the patient is located and helps in obtaining accurate results in a very short period of time. Market Analysis and Insights: Global Point of Care Diagnost…
- ポイントオブケア診断の世界市場（～2026年） Market Analysis and Insights: Global Point-of-Care Diagnostics Market The global Point-of-Care Diagnostics market size is projected to reach US$ 24030 million by 2026, from US$ 22640 million in 2020, at a CAGR of 5.7%% during 2021-2026. Global Point-of-Care Diagnostics Scope and Market Size Point-of…